Спонсоры
Lenalidomide Market Outlook Remains Positive Amid Industry Advancements
Market overview Lenalidomide Market size was valued at USD 10.39 billion in 2023. The market is anticipated to grow from USD 10.86 billion in 2024 to USD 15.67 billion by 2032, exhibiting the CAGR of 4.7% during the forecast period. Lenalidomide—an oral immunomodulatory agent used primarily in multiple myeloma and certain myelodysplastic syndromes (MDS), among other hematologic...
0 Комментарии 0 Поделились 57 Просмотры 0 предпросмотр